Abstract Details
John J. Halperin, MD, FAAN
(Overlook Medical Center)
PRESENTER |
Dr. Halperin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Halperin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Halperin has stock in Johnson & Johnson. The institution of Dr. Halperin has received research support from NIH. Dr. Halperin has received publishing royalties from a publication relating to health care. Dr. Halperin has received publishing royalties from a publication relating to health care. Dr. Halperin has received publishing royalties from a publication relating to health care. Dr. Halperin has received publishing royalties from a publication relating to health care. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Jan A. Hillert, MD (Karolinska Institute, Neurology R54) | Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche. |